News Focus
News Focus
icon url

rosemountbomber

01/02/25 9:47 AM

#432032 RE: JRoon71 #432031

I guess if you take the last quarterly revenue number of 42 million and multiply by 4 you get the 160 number you mention. I added the last 4 qtrs to yield a little over 240 million. Yours would be the more accurate going forward. Makes it seems that much harder to get to 500 million in 5 years. And you are correct that the US and EU markets are much different in terms of marketing. Without researching it, my guess would be that most new drugs have a significantly quicker uptake in terms of revenue here in the U.S. when compared to the EU.
icon url

Bullrunner2

01/02/25 10:33 AM

#432035 RE: JRoon71 #432031

Under big pharma this is a 1bill drug in 5 years. As prior idiotic mgmt said come to me at $25 and we can start talking. We can start talking at $5 now. Lol